Inter-regional Cohort of Neonatal and Infant Cholestasis in the Greater Southwest Region
NCT ID: NCT02767648
Last Updated: 2016-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
57 participants
OBSERVATIONAL
2010-05-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of the Stool Color Scale on the Detection of Neonatal Cholestasis
NCT06048211
Prenatal Ultrasound Screening of Intestinal Malrotation With a Higher Risk of Volvulus
NCT03356314
Screening for Bleeding Disorders in Children
NCT05214300
Transcutaneous Bilirubinometers in the Community
NCT00735319
Prenatal Screening of Intestinal Malrotation With a Higher Risk of Volvulus.
NCT05148429
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cholestasis
infant suffering from cholestasis proteomic urine analysis
proteomic urine analysis
proteomic urine analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
proteomic urine analysis
proteomic urine analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Year
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Broue, MD
Role: PRINCIPAL_INVESTIGATOR
UH Toulouse
Thierry Lamireau, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Jane Languepin, MD
Role: PRINCIPAL_INVESTIGATOR
UH Limoges
Sebastien Fournier-Favre, MD
Role: PRINCIPAL_INVESTIGATOR
UH Monptellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UH Bordeaux
Bordeaux, , France
UH Limoges
Limoges, , France
UH Montpellier
Montpellier, , France
UH Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
08 030 08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.